Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Roy Jones's publication output changed over time?
ScholarIQpublication output · 2005–2017
Output grew200% over the shown period — from 1 works in 2005 to 3 in 2017.
1
1
3
1
1
1
3
2005200820102012201420162017
What are the most-cited papers on Roy Jones?
ScholarIQmost cited works
Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
Clive Holmes, Delphine Boche, David Wilkinson, Ghasem Yadegarfar, Vivienne Hopkins, Anthony Bayer, Roy Jones, Roger Bullock, Seth Love, James Neal, Elina Zotova, James A. R. Nicoll
The Lancet. 20081,395 Citations
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
Robert Howard, Rupert McShane, James Lindesay, Craig Ritchie, Ashley Baldwin, Robert Barber, Alistair Burns, Tom Dening, David M. Findlay, Clive Holmes, Alan Hughes, Robin Jacoby, Rob Jones, Roy Jones, Ian G. McKeith, Ajay Macharouthu, John T. O’Brien, Peter Passmore, Bart Sheehan, Edmund Juszczak, Cornelius Katona, Robert K. Hills, Martín Knapp, Clive Ballard, Richard G. Brown, Sube Banerjee, Caroline Onions, Mary Griffin, Jessica Adams, Richard Gray, Tony Johnson, Peter Bentham, Patrick Phillips
New England Journal of Medicine. 2012772 CitationsOPEN ACCESS
On the path to 2025: understanding the Alzheimer’s disease continuum
Paul Aisen, Jeffrey L. Cummings, Clifford R. Jack, John C. Morris, Reisa A. Sperling, Lutz Frölich, Roy Jones, Sherie A. Dowsett, Brandy R. Matthews, Joel Raskin, Philip Scheltens, Bruno Dubois
S140755874. 2017563 CitationsOPEN ACCESS
Coherent concepts are computed in the anterior temporal lobes
Matthew A. Lambon Ralph, Karen Sage, Roy Jones, Emily Mayberry
Proceedings of the National Academy of Sciences. 2010501 CitationsOPEN ACCESS
Drug development in Alzheimer’s disease: the path to 2025
Jeffrey L. Cummings, Paul Aisen, Bruno Dubois, Lutz Frölich, Clifford R. Jack, Roy Jones, John C. Morris, Joel Raskin, Sherie A. Dowsett, Philip Scheltens
S140755874. 2016458 CitationsOPEN ACCESS
Related on ScholarIQ
The Research Institute for the Care of Older People
Institution
Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
Paper
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
Paper
On the path to 2025: understanding the Alzheimer’s disease continuum
Paper
Coherent concepts are computed in the anterior temporal lobes
Paper
Drug development in Alzheimer’s disease: the path to 2025
Paper